BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS, Cheng JQ. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol. 2008;28:6773-6784. [PMID: 18794355 DOI: 10.1128/mcb.00941-08] [Cited by in Crossref: 480] [Cited by in F6Publishing: 466] [Article Influence: 34.3] [Reference Citation Analysis]
Number Citing Articles
1 Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol 2022;15:129. [PMID: 36076302 DOI: 10.1186/s13045-022-01347-8] [Reference Citation Analysis]
2 Shi K, Wang G, Pei J, Zhang J, Wang J, Ouyang L, Wang Y, Li W. Emerging strategies to overcome resistance to third-generation EGFR inhibitors. J Hematol Oncol 2022;15:94. [PMID: 35840984 DOI: 10.1186/s13045-022-01311-6] [Reference Citation Analysis]
3 Chi LH, Cross RSN, Redvers RP, Davis M, Hediyeh-Zadeh S, Mathivanan S, Samuel M, Lucas EC, Mouchemore K, Gregory PA, Johnstone CN, Anderson RL. MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms. Oncogenesis 2022;11:38. [PMID: 35821197 DOI: 10.1038/s41389-022-00413-7] [Reference Citation Analysis]
4 Feng J, Hu S, Liu K, Sun G, Zhang Y. The Role of MicroRNA in the Regulation of Tumor Epithelial–Mesenchymal Transition. Cells 2022;11:1981. [DOI: 10.3390/cells11131981] [Reference Citation Analysis]
5 Tanga BM, Fang X, Bang S, Seong G, De Zoysa M, Saadeldin IM, Lee S, Cho J. MiRNA-155 inhibition enhances porcine embryo preimplantation developmental competence by upregulating ZEB2 and downregulating ATF4. Theriogenology 2022;183:90-7. [DOI: 10.1016/j.theriogenology.2022.02.019] [Reference Citation Analysis]
6 Mohamed AA, Allam AE, Aref AM, Mahmoud MO, Eldesoky NA, Fawazy N, Sakr Y, Sobeih ME, Albogami S, Fayad E, Althobaiti F, Jafri I, Alsharif G, El-sayed M, Abdelgeliel AS, Abdel Aziz RS. Evaluation of Expressed MicroRNAs as Prospective Biomarkers for Detection of Breast Cancer. Diagnostics 2022;12:789. [DOI: 10.3390/diagnostics12040789] [Reference Citation Analysis]
7 Aissa AF, Tryndyak VP, de Conti A, Rita Thomazela Machado A, Tuttis K, da Silva Machado C, Hernandes LC, Wellington da Silva Santos P, Mara Serpeloni J, P Pogribny I, Maria Greggi Antunes L. Epigenetic changes induced in mice liver by methionine-supplemented and methionine-deficient diets. Food Chem Toxicol 2022;163:112938. [PMID: 35314295 DOI: 10.1016/j.fct.2022.112938] [Reference Citation Analysis]
8 Xue M, Zhang X, Chen J, Liu F, Xu J, Xie J, Yang Y, Yu W, Qiu H, Najimi M. Mesenchymal Stem Cell-Secreted TGF-β1 Restores Treg/Th17 Skewing Induced by Lipopolysaccharide and Hypoxia Challenge via miR-155 Suppression. Stem Cells International 2022;2022:1-14. [DOI: 10.1155/2022/5522828] [Reference Citation Analysis]
9 Visal TH, den Hollander P, Cristofanilli M, Mani SA. Circulating tumour cells in the -omics era: how far are we from achieving the 'singularity'? Br J Cancer 2022. [PMID: 35273384 DOI: 10.1038/s41416-022-01768-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Dayakar A, Shanmukha KD, Kalangi SK. Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy. Mol Biol Rep 2022. [PMID: 35031927 DOI: 10.1007/s11033-021-07040-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Shelke V, Kale A, Sankrityayan H, Anders HJ, Gaikwad AB. Long non-coding RNAs as emerging regulators of miRNAs and epigenetics in diabetes-related chronic kidney disease. Arch Physiol Biochem 2022;:1-12. [PMID: 34986074 DOI: 10.1080/13813455.2021.2023580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Cao ZZ, Ao YJ, Zhou SH. The role of cancer stromal fibroblasts in mediating the effects of tobacco-induced cancer cell growth. Cancer Cell Int 2021;21:707. [PMID: 34953503 DOI: 10.1186/s12935-021-02414-9] [Reference Citation Analysis]
13 Shang M, Wu Y, Wang Y, Cai Y, Jin J, Yang Z. Dual antisense oligonucleotide targeting miR-21/miR-155 synergize photodynamic therapy to treat triple-negative breast cancer and inhibit metastasis. Biomed Pharmacother 2021;146:112564. [PMID: 34954643 DOI: 10.1016/j.biopha.2021.112564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Jarboe T, Tuli NY, Chakraborty S, Maniyar RR, DeSouza N, Xiu-Min Li, Moscatello A, Geliebter J, Tiwari RK. Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers. Adv Exp Med Biol 2021;1350:1-31. [PMID: 34888842 DOI: 10.1007/978-3-030-83282-7_1] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Chakraborty S, Carnazza M, Jarboe T, DeSouza N, Li XM, Moscatello A, Geliebter J, Tiwari RK. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity. Adv Exp Med Biol 2021;1350:33-66. [PMID: 34888843 DOI: 10.1007/978-3-030-83282-7_2] [Reference Citation Analysis]
16 Rahman M, Ravichandran R, Bansal S, Sanborn K, Bowen S, Eschbacher J, Sureshbabu A, Fleming T, Bharat A, Walia R, Hachem R, Bremner RM, Smith MA, Mohanakumar T. Novel role for tumor suppressor gene, liver kinase B1, in epithelial-mesenchymal transition leading to chronic lung allograft dysfunction. Am J Transplant 2021. [PMID: 34859569 DOI: 10.1111/ajt.16903] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Marima R, Francies FZ, Hull R, Molefi T, Oyomno M, Khanyile R, Mbatha S, Mabongo M, Owen Bates D, Dlamini Z. MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets. Biomedicines 2021;9:1818. [PMID: 34944633 DOI: 10.3390/biomedicines9121818] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Pakravan K, Razmara E, Mahmud Hussen B, Sattarikia F, Sadeghizadeh M, Babashah S. SMAD4 contributes to chondrocyte and osteocyte development. J Cell Mol Med 2021. [PMID: 34841647 DOI: 10.1111/jcmm.17080] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Gokavi J, Sadawarte S, Shelke A, Kulkarni-Kale U, Thakar M, Saxena V. Inhibition of miR-155 Promotes TGF-β Mediated Suppression of HIV Release in the Cervical Epithelial Cells. Viruses 2021;13:2266. [PMID: 34835072 DOI: 10.3390/v13112266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Song F, Zhang Y, Pan Z, Zhang Q, Lu X, Huang P. Resveratrol inhibits the migration, invasion and epithelial-mesenchymal transition in liver cancer cells through up- miR-186-5p expression. Zhejiang Da Xue Xue Bao Yi Xue Ban 2021;50:582-90. [PMID: 34986537 DOI: 10.3724/zdxbyxb-2021-0197] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Raigon Ponferrada A, Guerrero Orriach JL, Molina Ruiz JC, Romero Molina S, Gómez Luque A, Cruz Mañas J. Breast Cancer and Anaesthesia: Genetic Influence. Int J Mol Sci 2021;22:7653. [PMID: 34299272 DOI: 10.3390/ijms22147653] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Zhang B, Chen G, Yang X, Fan T, Chen X, Chen Z. Dysregulation of MicroRNAs in Hypertrophy and Ossification of Ligamentum Flavum: New Advances, Challenges, and Potential Directions. Front Genet 2021;12:641575. [PMID: 33912216 DOI: 10.3389/fgene.2021.641575] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Lin HJ, Yu SL, Su TC, Hsu HC, Chen MF, Lee YT, Chien KL, Lu TP. Statin-induced microRNAome alterations modulating inflammation pathways of peripheral blood mononuclear cells in patients with hypercholesterolemia. Biosci Rep 2020;40:BSR20201885. [PMID: 32885808 DOI: 10.1042/BSR20201885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Nurzadeh M, Naemi M, Sheikh Hasani S. A comprehensive review on oncogenic miRNAs in breast cancer. J Genet 2021;100. [DOI: 10.1007/s12041-021-01265-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Gollavilli PN, Parma B, Siddiqui A, Yang H, Ramesh V, Napoli F, Schwab A, Natesan R, Mielenz D, Asangani IA, Brabletz T, Pilarsky C, Ceppi P. The role of miR-200b/c in balancing EMT and proliferation revealed by an activity reporter. Oncogene 2021;40:2309-22. [PMID: 33654197 DOI: 10.1038/s41388-021-01708-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
26 Wani JA, Majid S, Khan A, Arafah A, Ahmad A, Jan BL, Shah NN, Kazi M, Rehman MU. Clinico-Pathological Importance of miR-146a in Lung Cancer. Diagnostics (Basel) 2021;11:274. [PMID: 33578944 DOI: 10.3390/diagnostics11020274] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
27 Galka-Marciniak P, Urbanek-Trzeciak MO, Nawrocka PM, Kozlowski P. A pan-cancer atlas of somatic mutations in miRNA biogenesis genes. Nucleic Acids Res 2021;49:601-20. [PMID: 33406242 DOI: 10.1093/nar/gkaa1223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
28 Pan G, Liu Y, Shang L, Zhou F, Yang S. EMT-associated microRNAs and their roles in cancer stemness and drug resistance. Cancer Commun (Lond) 2021;41:199-217. [PMID: 33506604 DOI: 10.1002/cac2.12138] [Cited by in Crossref: 7] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
29 Hu YM, Lou XL, Liu BZ, Sun L, Wan S, Wu L, Zhao X, Zhou Q, Sun MM, Tao K, Zhang YS, Wang SL. TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression. Asian J Androl 2021;23:188-96. [PMID: 33159025 DOI: 10.4103/aja.aja_60_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
30 Aalami AH, Mesgari M, Sahebkar A. Synthesis and Characterization of Green Zinc Oxide Nanoparticles with Antiproliferative Effects through Apoptosis Induction and MicroRNA Modulation in Breast Cancer Cells. Bioinorg Chem Appl 2020;2020:8817110. [PMID: 33273900 DOI: 10.1155/2020/8817110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
31 Zhou L, Zhang Z, Huang Z, Nice E, Zou B, Huang C. Revisiting cancer hallmarks: insights from the interplay between oxidative stress and non-coding RNAs. Mol Biomed 2020;1:4. [PMID: 35006436 DOI: 10.1186/s43556-020-00004-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Pasculli B, Barbano R, Fontana A, Biagini T, Di Viesti MP, Rendina M, Valori VM, Morritti M, Bravaccini S, Ravaioli S, Maiello E, Graziano P, Murgo R, Copetti M, Mazza T, Fazio VM, Esteller M, Parrella P. Hsa-miR-155-5p Up-Regulation in Breast Cancer and Its Relevance for Treatment With Poly[ADP-Ribose] Polymerase 1 (PARP-1) Inhibitors. Front Oncol 2020;10:1415. [PMID: 32903519 DOI: 10.3389/fonc.2020.01415] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
33 Li J, Kwok HF. Current Strategies for Treating NSCLC: From Biological Mechanisms to Clinical Treatment. Cancers (Basel) 2020;12:E1587. [PMID: 32549388 DOI: 10.3390/cancers12061587] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
34 Das PK, Islam F, Lam AK. The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma. Cells 2020;9:E1392. [PMID: 32503256 DOI: 10.3390/cells9061392] [Cited by in Crossref: 19] [Cited by in F6Publishing: 41] [Article Influence: 9.5] [Reference Citation Analysis]
35 Zhang Y, Saradna A, Ratan R, Ke X, Tu W, Do DC, Hu C, Gao P. RhoA/Rho-kinases in asthma: from pathogenesis to therapeutic targets. Clin Transl Immunology 2020;9:e01134. [PMID: 32355562 DOI: 10.1002/cti2.1134] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
36 Li X, Wang J. Mechanical tumor microenvironment and transduction: cytoskeleton mediates cancer cell invasion and metastasis. Int J Biol Sci 2020;16:2014-28. [PMID: 32549750 DOI: 10.7150/ijbs.44943] [Cited by in Crossref: 20] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
37 Prabhu KS, Raza A, Karedath T, Raza SS, Fathima H, Ahmed EI, Kuttikrishnan S, Therachiyil L, Kulinski M, Dermime S, Junejo K, Steinhoff M, Uddin S. Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells. Cancers (Basel) 2020;12:E351. [PMID: 32033146 DOI: 10.3390/cancers12020351] [Cited by in Crossref: 15] [Cited by in F6Publishing: 22] [Article Influence: 7.5] [Reference Citation Analysis]
38 Schjenken JE, Moldenhauer LM, Zhang B, Care AS, Groome HM, Chan HY, Hope CM, Barry SC, Robertson SA. MicroRNA miR-155 is required for expansion of regulatory T cells to mediate robust pregnancy tolerance in mice. Mucosal Immunol 2020;13:609-25. [PMID: 31988469 DOI: 10.1038/s41385-020-0255-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
39 Cui L, Lyu Y, Jin X, Wang Y, Li X, Wang J, Zhang J, Deng Z, Yang N, Zheng Z, Guo Y, Wang C, Mao R, Xu J, Gao F, Jin C, Zhang J, Tian H, Xu GT, Lu L. miR-194 suppresses epithelial-mesenchymal transition of retinal pigment epithelial cells by directly targeting ZEB1. Ann Transl Med 2019;7:751. [PMID: 32042767 DOI: 10.21037/atm.2019.11.90] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
40 Kapral M, Wawszczyk J, Węglarz L. Regulation of MicroRNA-155 and Its Related Genes Expression by Inositol Hexaphosphate in Colon Cancer Cells. Molecules 2019;24:E4153. [PMID: 31744065 DOI: 10.3390/molecules24224153] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
41 Wang R, Liu X. Epigenetic regulation of prostate cancer. Genes Dis 2020;7:606-13. [PMID: 33335960 DOI: 10.1016/j.gendis.2019.10.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
42 Fridrichova I, Zmetakova I. MicroRNAs Contribute to Breast Cancer Invasiveness. Cells 2019;8:E1361. [PMID: 31683635 DOI: 10.3390/cells8111361] [Cited by in Crossref: 25] [Cited by in F6Publishing: 47] [Article Influence: 8.3] [Reference Citation Analysis]
43 Rawat M, Kadian K, Gupta Y, Kumar A, Chain PSG, Kovbasnjuk O, Kumar S, Parasher G. MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential. Genes (Basel) 2019;10:E752. [PMID: 31557962 DOI: 10.3390/genes10100752] [Cited by in Crossref: 27] [Cited by in F6Publishing: 42] [Article Influence: 9.0] [Reference Citation Analysis]
44 Ko J, Mills T, Huang J, Chen NY, Mertens TCJ, Collum SD, Lee G, Xiang Y, Han L, Zhou Y, Lee CG, Elias JA, Jyothula SSK, Rajagopal K, Karmouty-Quintana H, Blackburn MR. Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis. J Biol Chem 2019;294:15781-94. [PMID: 31488543 DOI: 10.1074/jbc.RA119.009148] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
45 Sheervalilou R, Lotfi H, Shirvaliloo M, Sharifi A, Nazemiyeh M, Zarghami N. Circulating MiR-10b, MiR-1 and MiR-30a Expression Profiles in Lung Cancer: Possible Correlation with Clinico-pathologic Characteristics and Lung Cancer Detection. Int J Mol Cell Med 2019;8:118-29. [PMID: 32215263 DOI: 10.22088/IJMCM.BUMS.8.2.118] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
46 Sun B, Fan Y, Yang A, Liang L, Cao J. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1. J Cell Mol Med 2019;23:5934-48. [PMID: 31298493 DOI: 10.1111/jcmm.14402] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
47 Voena C, Chiarle R. RHO Family GTPases in the Biology of Lymphoma. Cells 2019;8:E646. [PMID: 31248017 DOI: 10.3390/cells8070646] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
48 Hao Y, Baker D, Ten Dijke P. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis. Int J Mol Sci 2019;20:E2767. [PMID: 31195692 DOI: 10.3390/ijms20112767] [Cited by in Crossref: 180] [Cited by in F6Publishing: 308] [Article Influence: 60.0] [Reference Citation Analysis]
49 Müller-Deile J, Dannenberg J, Liu P, Lorenzen J, Nyström J, Thum T, Schiffer M. Identification of cell and disease specific microRNAs in glomerular pathologies. J Cell Mol Med 2019;23:3927-39. [PMID: 30950172 DOI: 10.1111/jcmm.14270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
50 Mahesh G, Biswas R. MicroRNA-155: A Master Regulator of Inflammation. J Interferon Cytokine Res 2019;39:321-30. [PMID: 30998423 DOI: 10.1089/jir.2018.0155] [Cited by in Crossref: 37] [Cited by in F6Publishing: 78] [Article Influence: 12.3] [Reference Citation Analysis]
51 Wu SG, Chang TH, Liu YN, Shih JY. MicroRNA in Lung Cancer Metastasis. Cancers (Basel) 2019;11:E265. [PMID: 30813457 DOI: 10.3390/cancers11020265] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 9.7] [Reference Citation Analysis]
52 Si W, Shen J, Zheng H, Fan W. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin Epigenetics. 2019;11:25. [PMID: 30744689 DOI: 10.1186/s13148-018-0587-8] [Cited by in Crossref: 146] [Cited by in F6Publishing: 237] [Article Influence: 48.7] [Reference Citation Analysis]
53 Felden B, Gilot D. Modulation of Bacterial sRNAs Activity by Epigenetic Modifications: Inputs from the Eukaryotic miRNAs. Genes (Basel) 2018;10:E22. [PMID: 30602712 DOI: 10.3390/genes10010022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
54 Matsuura Y, Wada H, Eguchi H, Gotoh K, Kobayashi S, Kinoshita M, Kubo M, Hayashi K, Iwagami Y, Yamada D, Asaoka T, Noda T, Kawamoto K, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M. Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells. Dig Dis Sci 2019;64:792-802. [PMID: 30465177 DOI: 10.1007/s10620-018-5380-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 54] [Article Influence: 12.0] [Reference Citation Analysis]
55 Tsubakihara Y, Moustakas A. Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β.Int J Mol Sci. 2018;19. [PMID: 30463358 DOI: 10.3390/ijms19113672] [Cited by in Crossref: 60] [Cited by in F6Publishing: 71] [Article Influence: 15.0] [Reference Citation Analysis]
56 Yerukala Sathipati S, Ho SY. Identifying a miRNA signature for predicting the stage of breast cancer. Sci Rep 2018;8:16138. [PMID: 30382159 DOI: 10.1038/s41598-018-34604-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 52] [Article Influence: 9.8] [Reference Citation Analysis]
57 Shee K, Muller KE, Marotti J, Miller TW, Wells WA, Tsongalis GJ. Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era: Current and Future Molecular-Based Testing. Am J Pathol 2019;189:956-65. [PMID: 30385093 DOI: 10.1016/j.ajpath.2018.08.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
58 Haun F, Neumann S, Peintner L, Wieland K, Habicht J, Schwan C, Østevold K, Koczorowska MM, Biniossek M, Kist M, Busch H, Boerries M, Davis RJ, Maurer U, Schilling O, Aktories K, Borner C. Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin. Nat Commun 2018;9:3524. [PMID: 30166526 DOI: 10.1038/s41467-018-05850-w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
59 Lorenzo-Martín LF, Citterio C, Menacho-Márquez M, Conde J, Larive RM, Rodríguez-Fdez S, García-Escudero R, Robles-Valero J, Cuadrado M, Fernández-Pisonero I, Dosil M, Sevilla MA, Montero MJ, Fernández-Salguero PM, Paramio JM, Bustelo XR. Vav proteins maintain epithelial traits in breast cancer cells using miR-200c-dependent and independent mechanisms. Oncogene 2019;38:209-27. [PMID: 30087437 DOI: 10.1038/s41388-018-0433-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
60 Chen H, Dai G, Cai Y, Gong Q, Wu W, Gao M, Fei Z. Vasodilator-stimulated phosphoprotein (VASP), a novel target of miR-4455, promotes gastric cancer cell proliferation, migration, and invasion, through activating the PI3K/AKT signaling pathway. Cancer Cell Int 2018;18:97. [PMID: 30002604 DOI: 10.1186/s12935-018-0573-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
61 Wu X, Wang Y, Yu T, Nie E, Hu Q, Wu W, Zhi T, Jiang K, Wang X, Lu X, Li H, Liu N, Zhang J, You Y. Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma. Neuro Oncol 2017;19:1195-205. [PMID: 28371892 DOI: 10.1093/neuonc/nox017] [Cited by in Crossref: 55] [Cited by in F6Publishing: 72] [Article Influence: 13.8] [Reference Citation Analysis]
62 Suzuki HI. MicroRNA Control of TGF-β Signaling. Int J Mol Sci 2018;19:E1901. [PMID: 29958433 DOI: 10.3390/ijms19071901] [Cited by in Crossref: 50] [Cited by in F6Publishing: 61] [Article Influence: 12.5] [Reference Citation Analysis]
63 Wang SE, Lin RJ. MicroRNA and HER2-overexpressing cancer. Microrna 2013;2:137-47. [PMID: 25070783 DOI: 10.2174/22115366113029990011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
64 Gao S, Wang Y, Wang M, Li Z, Zhao Z, Wang RX, Wu R, Yuan Z, Cui R, Jiao K, Wang L, Ouyang L, Liu R. MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer. Oncotarget 2017;8:41451-64. [PMID: 28562349 DOI: 10.18632/oncotarget.17816] [Cited by in Crossref: 20] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
65 Zhou X, Mao Y, Zhu J, Meng F, Chen Q, Tao L, Li R, Fu F, Liu C, Hu Y, Wang W, Zhang H, Hua D, Chen W, Zhang X. TGF-β1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis. Oncotarget 2016;7:67196-211. [PMID: 27626488 DOI: 10.18632/oncotarget.11950] [Cited by in Crossref: 41] [Cited by in F6Publishing: 48] [Article Influence: 10.3] [Reference Citation Analysis]
66 Sekhon K, Bucay N, Majid S, Dahiya R, Saini S. MicroRNAs and epithelial-mesenchymal transition in prostate cancer. Oncotarget 2016;7:67597-611. [PMID: 27588490 DOI: 10.18632/oncotarget.11708] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 6.5] [Reference Citation Analysis]
67 Gao Y, Liu Z, Ding Z, Hou S, Li J, Jiang K. MicroRNA-155 increases colon cancer chemoresistance to cisplatin by targeting forkhead box O3. Oncol Lett 2018;15:4781-8. [PMID: 29552117 DOI: 10.3892/ol.2018.7976] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
68 Alivernini S, Gremese E, McSharry C, Tolusso B, Ferraccioli G, McInnes IB, Kurowska-Stolarska M. MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. Front Immunol 2017;8:1932. [PMID: 29354135 DOI: 10.3389/fimmu.2017.01932] [Cited by in Crossref: 77] [Cited by in F6Publishing: 91] [Article Influence: 19.3] [Reference Citation Analysis]
69 Chernyy V, Pustylnyak V, Kozlov V, Gulyaeva L. Increased expression of miR-155 and miR-222 is associated with lymph node positive status. J Cancer 2018;9:135-40. [PMID: 29290778 DOI: 10.7150/jca.22181] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
70 Kramer EL, Clancy JP. TGFβ as a therapeutic target in cystic fibrosis. Expert Opin Ther Targets 2018;22:177-89. [PMID: 29168406 DOI: 10.1080/14728222.2018.1406922] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
71 Soon PS, Provan PJ, Kim E, Pathmanathan N, Graham D, Clarke CL, Balleine RL. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study. Clin Exp Metastasis 2018;35:3-13. [PMID: 29214365 DOI: 10.1007/s10585-017-9868-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
72 Al-Haidari AA, Syk I, Thorlacius H. MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoA. Oncotarget 2017;8:14887-96. [PMID: 28146427 DOI: 10.18632/oncotarget.14841] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
73 Wang J, He W, Xu X, Guo L, Zhang Y, Han S, Shen D. The mechanism of TGF-β/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells. Biosci Rep 2017;37:BSR20160603. [PMID: 28607031 DOI: 10.1042/BSR20160603] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
74 Amawi H, Ashby CR, Samuel T, Peraman R, Tiwari AK. Polyphenolic Nutrients in Cancer Chemoprevention and Metastasis: Role of the Epithelial-to-Mesenchymal (EMT) Pathway. Nutrients 2017;9:E911. [PMID: 28825675 DOI: 10.3390/nu9080911] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 8.4] [Reference Citation Analysis]
75 Artlett CM, Sassi-Gaha S, Hope JL, Feghali-Bostwick CA, Katsikis PD. Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis. Arthritis Res Ther 2017;19:144. [PMID: 28623945 DOI: 10.1186/s13075-017-1331-z] [Cited by in Crossref: 60] [Cited by in F6Publishing: 73] [Article Influence: 12.0] [Reference Citation Analysis]
76 Shooshtarian B, Mohammadi-asl J, Kohan L. The Diagnostic Value of miR-155 Expression in the Serum of Patients with Breast Cancer According to Molecular Subtypes of Breast Cancer. Jentashapir J Helath Res 2017;8. [DOI: 10.5812/jjhr.59937] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
77 Yao Y, Vasoya D, Kgosana L, Smith LP, Gao Y, Wang X, Watson M, Nair V. Activation of gga-miR-155 by reticuloendotheliosis virus T strain and its contribution to transformation. J Gen Virol 2017;98:810-20. [PMID: 28113043 DOI: 10.1099/jgv.0.000718] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
78 Zhao H, Zhang J, Shao H, Liu J, Jin M, Chen J, Huang Y. Transforming Growth Factor β1/Smad4 Signaling Affects Osteoclast Differentiation via Regulation of miR-155 Expression. Mol Cells 2017;40:211-21. [PMID: 28359146 DOI: 10.14348/molcells.2017.2303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
79 Zhu FQ, Zeng L, Tang N, Tang YP, Zhou BP, Li FF, Wu WG, Zeng XB, Peng SS. MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma. Oncol Res 2016;24:415-27. [PMID: 28281962 DOI: 10.3727/096504016X14685034103473] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
80 Luu HN, Lin HY, Sørensen KD, Ogunwobi OO, Kumar N, Chornokur G, Phelan C, Jones D, Kidd L, Batra J, Yamoah K, Berglund A, Rounbehler RJ, Yang M, Lee SH, Kang N, Kim SJ, Park JY, Di Pietro G. miRNAs associated with prostate cancer risk and progression. BMC Urol 2017;17:18. [PMID: 28320379 DOI: 10.1186/s12894-017-0206-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 58] [Article Influence: 10.0] [Reference Citation Analysis]
81 Smith B, Agarwal P, Bhowmick NA. MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine. Endocr Relat Cancer 2017;24:R157-72. [PMID: 28289080 DOI: 10.1530/ERC-16-0525] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
82 Liang D, Wang Z, Yan Z, Hou S, Xu W, Wang L, Shang M, Qiao Z. Nicotine facilitates VSMC dysfunction through a miR-200b/RhoGDIA/cytoskeleton module. Sci Rep 2017;7:43798. [PMID: 28252009 DOI: 10.1038/srep43798] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
83 Kumar AS, Jagadeeshan S, Pitani RS, Ramshankar V, Venkitasamy K, Venkatraman G, Rayala SK. Snail-Modulated MicroRNA 493 Forms a Negative Feedback Loop with the Insulin-Like Growth Factor 1 Receptor Pathway and Blocks Tumorigenesis. Mol Cell Biol 2017;37:e00510-16. [PMID: 27956702 DOI: 10.1128/MCB.00510-16] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
84 Li Z, Lan X, Han R, Wang J, Huang Y, Sun J, Guo W, Chen H. miR-2478 inhibits TGFβ1 expression by targeting the transcriptional activation region downstream of the TGFβ1 promoter in dairy goats. Sci Rep 2017;7:42627. [PMID: 28198456 DOI: 10.1038/srep42627] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
85 Shi ZM, Wang L, Shen H, Jiang CF, Ge X, Li DM, Wen YY, Sun HR, Pan MH, Li W, Shu YQ, Liu LZ, Peiper SC, He J, Jiang BH. Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling. Oncogene 2017;36:2577-88. [PMID: 28192397 DOI: 10.1038/onc.2016.414] [Cited by in Crossref: 82] [Cited by in F6Publishing: 94] [Article Influence: 16.4] [Reference Citation Analysis]
86 Tang R, Yang C, Ma X, Wang Y, Luo D, Huang C, Xu Z, Liu P, Yang L. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer. Oncotarget. 2016;7:5972-5984. [PMID: 26745603 DOI: 10.18632/oncotarget.6821] [Cited by in Crossref: 52] [Cited by in F6Publishing: 64] [Article Influence: 10.4] [Reference Citation Analysis]
87 Martinez-Ruiz H, Illa-Bochaca I, Omene C, Hanniford D, Liu Q, Hernando E, Barcellos-Hoff MH. A TGFβ-miR-182-BRCA1 axis controls the mammary differentiation hierarchy. Sci Signal 2016;9:ra118. [PMID: 27923913 DOI: 10.1126/scisignal.aaf5402] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
88 Sharma S, Patnaik PK, Aronov S, Kulshreshtha R. ApoptomiRs of Breast Cancer: Basics to Clinics. Front Genet 2016;7:175. [PMID: 27746811 DOI: 10.3389/fgene.2016.00175] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
89 Haga RB, Ridley AJ. Rho GTPases: Regulation and roles in cancer cell biology. Small GTPases 2016;7:207-21. [PMID: 27628050 DOI: 10.1080/21541248.2016.1232583] [Cited by in Crossref: 165] [Cited by in F6Publishing: 201] [Article Influence: 27.5] [Reference Citation Analysis]
90 Park JH, Theodoratou E, Calin GA, Shin JI. From cell biology to immunology: Controlling metastatic progression of cancer via microRNA regulatory networks. Oncoimmunology 2016;5:e1230579. [PMID: 27999740 DOI: 10.1080/2162402X.2016.1230579] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
91 Thomsen KG, Terp MG, Lund RR, Søkilde R, Elias D, Bak M, Litman T, Beck HC, Lyng MB, Ditzel HJ. miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations. Oncotarget 2015;6:29224-39. [PMID: 26317550 DOI: 10.18632/oncotarget.4942] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
92 Szűcs D, Béres NJ, Rokonay R, Boros K, Borka K, Kiss Z, Arató A, Szabó AJ, Vannay &, Sziksz E, Bereczki C, Veres G. Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(26): 6027-6035 [PMID: 27468194 DOI: 10.3748/wjg.v22.i26.6027] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
93 Moustakas A, Heldin CH. Mechanisms of TGFβ-Induced Epithelial-Mesenchymal Transition. J Clin Med 2016;5:E63. [PMID: 27367735 DOI: 10.3390/jcm5070063] [Cited by in Crossref: 141] [Cited by in F6Publishing: 130] [Article Influence: 23.5] [Reference Citation Analysis]
94 Cerutti C, Soblechero-Martin P, Wu D, Lopez-Ramirez MA, de Vries H, Sharrack B, Male DK, Romero IA. MicroRNA-155 contributes to shear-resistant leukocyte adhesion to human brain endothelium in vitro. Fluids Barriers CNS 2016;13:8. [PMID: 27246706 DOI: 10.1186/s12987-016-0032-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
95 Tomasetti M, Amati M, Santarelli L, Neuzil J. MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis. Int J Mol Sci 2016;17:E754. [PMID: 27213336 DOI: 10.3390/ijms17050754] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
96 Wan J, Xia L, Xu W, Lu N. Expression and Function of miR-155 in Diseases of the Gastrointestinal Tract.Int J Mol Sci. 2016;17. [PMID: 27187359 DOI: 10.3390/ijms17050709] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
97 Liu Q, Wang W, Yang X, Zhao D, Li F, Wang H. MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer. Oncol Rep 2016;36:189-96. [PMID: 27175941 DOI: 10.3892/or.2016.4788] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
98 Li YP, Wei XC, Li PC, Chen CW, Wang XH, Jiao Q, Wang DM, Wei FY, Zhang JZ, Wei L. The Role of miRNAs in Cartilage Homeostasis. Curr Genomics 2015;16:393-404. [PMID: 27019614 DOI: 10.2174/1389202916666150817203144] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
99 Yin Q, Wang X, Roberts C, Flemington EK, Lasky JA. Methylation status and AP1 elements are involved in EBV-mediated miR-155 expression in EBV positive lymphoma cells. Virology 2016;494:158-67. [PMID: 27110708 DOI: 10.1016/j.virol.2016.04.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
100 Chiu CF, Chang YW, Kuo KT, Shen YS, Liu CY, Yu YH, Cheng CC, Lee KY, Chen FC, Hsu MK, Kuo TC, Ma JT, Su JL. NF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance. Proc Natl Acad Sci U S A 2016;113:E2526-35. [PMID: 27091996 DOI: 10.1073/pnas.1522612113] [Cited by in Crossref: 43] [Cited by in F6Publishing: 53] [Article Influence: 7.2] [Reference Citation Analysis]
101 He XH, Zhu W, Yuan P, Jiang S, Li D, Zhang HW, Liu MF. miR-155 downregulates ErbB2 and suppresses ErbB2-induced malignant transformation of breast epithelial cells. Oncogene 2016;35:6015-25. [PMID: 27065318 DOI: 10.1038/onc.2016.132] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
102 Osaka E, Kelly AD, Spentzos D, Choy E, Yang X, Shen JK, Yang P, Mankin HJ, Hornicek FJ, Duan Z. MicroRNA-155 expression is independently predictive of outcome in chordoma. Oncotarget 2015;6:9125-39. [PMID: 25823817 DOI: 10.18632/oncotarget.3273] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
103 Ma T, Xue YX. MiRNA-200b Regulates RMP7-Induced Increases in Blood-Tumor Barrier Permeability by Targeting RhoA and ROCKII. Front Mol Neurosci 2016;9:9. [PMID: 26903801 DOI: 10.3389/fnmol.2016.00009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
104 Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther 2016;1:15004. [PMID: 29263891 DOI: 10.1038/sigtrans.2015.4] [Cited by in Crossref: 749] [Cited by in F6Publishing: 961] [Article Influence: 124.8] [Reference Citation Analysis]
105 Wu Y, Sarkissyan M, Vadgama JV. Epithelial-Mesenchymal Transition and Breast Cancer. J Clin Med 2016;5:E13. [PMID: 26821054 DOI: 10.3390/jcm5020013] [Cited by in Crossref: 103] [Cited by in F6Publishing: 96] [Article Influence: 17.2] [Reference Citation Analysis]
106 Li Y, Lauriola M, Kim D, Francesconi M, D'Uva G, Shibata D, Malafa MP, Yeatman TJ, Coppola D, Solmi R, Cheng JQ. Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer. Oncogene 2016;35:4558-68. [PMID: 26804172 DOI: 10.1038/onc.2015.522] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
107 Velázquez KT, Enos RT, McClellan JL, Cranford TL, Chatzistamou I, Singh UP, Nagarkatti M, Nagarkatti PS, Fan D, Murphy EA. MicroRNA-155 deletion promotes tumorigenesis in the azoxymethane-dextran sulfate sodium model of colon cancer. Am J Physiol Gastrointest Liver Physiol. 2016;310:G347-G358. [PMID: 26744471 DOI: 10.1152/ajpgi.00326.2015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
108 Arora A, Singh S, Bhatt AN, Pandey S, Sandhir R, Dwarakanath BS. Interplay Between Metabolism and Oncogenic Process: Role of microRNAs. Transl Oncogenomics 2015;7:11-27. [PMID: 26740741 DOI: 10.4137/TOG.S29652] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
109 Goldgraben MA, Russell R, Rueda OM, Caldas C, Git A. Double-stranded microRNA mimics can induce length- and passenger strand-dependent effects in a cell type-specific manner. RNA 2016;22:193-203. [PMID: 26670622 DOI: 10.1261/rna.054072.115] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
110 Shields BB, Pecot CV, Gao H, McMillan E, Potts M, Nagel C, Purinton S, Wang Y, Ivan C, Kim HS, Borkowski RJ, Khan S, Rodriguez-Aguayo C, Lopez-Berestein G, Lea J, Gazdar A, Baggerly KA, Sood AK, White MA. A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression. Mol Syst Biol 2015;11:842. [PMID: 26655797 DOI: 10.15252/msb.20156308] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
111 Fierro-Fernández M, Miguel V, Lamas S. Role of redoximiRs in fibrogenesis. Redox Biol 2016;7:58-67. [PMID: 26654978 DOI: 10.1016/j.redox.2015.11.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
112 Guo L, Zhang Y, Zhang L, Huang F, Li J, Wang S. MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancer. Tumour Biol 2016;37:115-25. [PMID: 26563372 DOI: 10.1007/s13277-015-4374-2] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 8.3] [Reference Citation Analysis]
113 Sun T, Kalionis B, Lv G, Xia S, Gao W. Role of Exosomal Noncoding RNAs in Lung Carcinogenesis. Biomed Res Int 2015;2015:125807. [PMID: 26583084 DOI: 10.1155/2015/125807] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
114 Liu M, Zhou K, Huang Y, Cao Y. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway. J Exp Clin Cancer Res 2015;34:121. [PMID: 26467212 DOI: 10.1186/s13046-015-0235-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
115 Liu T, Nie F, Yang X, Wang X, Yuan Y, Lv Z, Zhou L, Peng R, Ni D, Gu Y, Zhou Q, Weng Y. MicroRNA-590 is an EMT-suppressive microRNA involved in the TGFβ signaling pathway. Mol Med Rep 2015;12:7403-11. [PMID: 26459119 DOI: 10.3892/mmr.2015.4374] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
116 Woodbury ME, Freilich RW, Cheng CJ, Asai H, Ikezu S, Boucher JD, Slack F, Ikezu T. miR-155 Is Essential for Inflammation-Induced Hippocampal Neurogenic Dysfunction. J Neurosci 2015;35:9764-81. [PMID: 26134658 DOI: 10.1523/JNEUROSCI.4790-14.2015] [Cited by in Crossref: 58] [Cited by in F6Publishing: 64] [Article Influence: 8.3] [Reference Citation Analysis]
117 Huang L, Wang X, Wen C, Yang X, Song M, Chen J, Wang C, Zhang B, Wang L, Iwamoto A, Wang J, Liu H. Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer. Sci Rep 2015;5:13350. [PMID: 26302825 DOI: 10.1038/srep13350] [Cited by in Crossref: 44] [Cited by in F6Publishing: 52] [Article Influence: 6.3] [Reference Citation Analysis]
118 Sun M, Huang F, Yu D, Zhang Y, Xu H, Zhang L, Li L, Dong L, Guo L, Wang S. Autoregulatory loop between TGF-β1/miR-411-5p/SPRY4 and MAPK pathway in rhabdomyosarcoma modulates proliferation and differentiation. Cell Death Dis 2015;6:e1859. [PMID: 26291313 DOI: 10.1038/cddis.2015.225] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
119 Campo L, Zhang C, Breuer EK. EMT-Inducing Molecular Factors in Gynecological Cancers. Biomed Res Int 2015;2015:420891. [PMID: 26356073 DOI: 10.1155/2015/420891] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
120 Romero-Cordoba SL, Salido-Guadarrama I, Rodriguez-Dorantes M, Hidalgo-Miranda A. miRNA biogenesis: biological impact in the development of cancer. Cancer Biol Ther 2014;15:1444-55. [PMID: 25482951 DOI: 10.4161/15384047.2014.955442] [Cited by in Crossref: 136] [Cited by in F6Publishing: 147] [Article Influence: 19.4] [Reference Citation Analysis]
121 Cao Q, Zhao L, Wang P. [Advances in the molecular mechanisms and prognostic significance of EMT in non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi 2014;17:569-74. [PMID: 25034589 DOI: 10.3779/j.issn.1009-3419.2014.07.13] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
122 Hagrass HA, Sharaf S, Pasha HF, Tantawy EA, Mohamed RH, Kassem R. Circulating microRNAs - a new horizon in molecular diagnosis of breast cancer. Genes Cancer 2015;6:281-7. [PMID: 26124926 DOI: 10.18632/genesandcancer.66] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
123 Gissen P, Arias IM. Structural and functional hepatocyte polarity and liver disease. J Hepatol. 2015;63:1023-1037. [PMID: 26116792 DOI: 10.1016/j.jhep.2015.06.015] [Cited by in Crossref: 130] [Cited by in F6Publishing: 136] [Article Influence: 18.6] [Reference Citation Analysis]
124 Zhou L, Liu F, Wang X, Ouyang G. The roles of microRNAs in the regulation of tumor metastasis. Cell Biosci 2015;5:32. [PMID: 26146543 DOI: 10.1186/s13578-015-0028-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
125 Urbanek MO, Nawrocka AU, Krzyzosiak WJ. Small RNA Detection by in Situ Hybridization Methods. Int J Mol Sci 2015;16:13259-86. [PMID: 26068454 DOI: 10.3390/ijms160613259] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 8.3] [Reference Citation Analysis]
126 Taylor MA, Schiemann WP. Therapeutic Opportunities for Targeting microRNAs in Cancer. Mol Cell Ther. 2014;2:1-13. [PMID: 25717380 DOI: 10.1186/2052-8426-2-30] [Cited by in Crossref: 19] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
127 Pathak S, Grillo AR, Scarpa M, Brun P, D’Incà R, Nai L, Banerjee A, Cavallo D, Barzon L, Palù G. MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis. Exp Mol Med. 2015;47:e164. [PMID: 25998827 DOI: 10.1038/emm.2015.21] [Cited by in Crossref: 47] [Cited by in F6Publishing: 58] [Article Influence: 6.7] [Reference Citation Analysis]
128 Macara IG, Guyer R, Richardson G, Huo Y, Ahmed SM. Epithelial homeostasis. Curr Biol 2014;24:R815-25. [PMID: 25202877 DOI: 10.1016/j.cub.2014.06.068] [Cited by in Crossref: 87] [Cited by in F6Publishing: 86] [Article Influence: 12.4] [Reference Citation Analysis]
129 Eastlack SC, Alahari SK. MicroRNA and Breast Cancer: Understanding Pathogenesis, Improving Management. Noncoding RNA 2015;1:17-43. [PMID: 29861413 DOI: 10.3390/ncrna1010017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
130 Arts N, Cané S, Hennequart M, Lamy J, Bommer G, Van den Eynde B, De Plaen E. microRNA-155, induced by interleukin-1ß, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells. PLoS One 2015;10:e0122517. [PMID: 25853464 DOI: 10.1371/journal.pone.0122517] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
131 Zaravinos A. The Regulatory Role of MicroRNAs in EMT and Cancer. J Oncol. 2015;2015:865816. [PMID: 25883654 DOI: 10.1155/2015/865816] [Cited by in Crossref: 160] [Cited by in F6Publishing: 180] [Article Influence: 22.9] [Reference Citation Analysis]
132 Yu DD, Lv MM, Chen WX, Zhong SL, Zhang XH, Chen L, Ma TF, Tang JH, Zhao JH. Role of miR-155 in drug resistance of breast cancer. Tumour Biol 2015;36:1395-401. [PMID: 25744731 DOI: 10.1007/s13277-015-3263-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
133 Lian JY, Tuo BG. Role of non-coding RNAs in development and progression of hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2015; 23(3): 396-403 [DOI: 10.11569/wcjd.v23.i3.396] [Reference Citation Analysis]
134 Richards EJ, Zhang G, Li ZP, Permuth-Wey J, Challa S, Li Y, Kong W, Dan S, Bui MM, Coppola D, Mao WM, Sellers TA, Cheng JQ. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia. J Biol Chem 2015;290:6857-67. [PMID: 25605728 DOI: 10.1074/jbc.M114.610915] [Cited by in Crossref: 103] [Cited by in F6Publishing: 109] [Article Influence: 14.7] [Reference Citation Analysis]
135 Rachagani S, Macha MA, Heimann N, Seshacharyulu P, Haridas D, Chugh S, Batra SK. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. Adv Drug Deliv Rev 2015;81:16-33. [PMID: 25453266 DOI: 10.1016/j.addr.2014.10.020] [Cited by in Crossref: 57] [Cited by in F6Publishing: 65] [Article Influence: 8.1] [Reference Citation Analysis]
136 Dai X, Tan C. Combination of microRNA therapeutics with small-molecule anticancer drugs: mechanism of action and co-delivery nanocarriers. Adv Drug Deliv Rev 2015;81:184-97. [PMID: 25281917 DOI: 10.1016/j.addr.2014.09.010] [Cited by in Crossref: 99] [Cited by in F6Publishing: 98] [Article Influence: 14.1] [Reference Citation Analysis]
137 Lv ZC, Fan YS, Chen HB, Zhao DW. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer. Tumour Biol. 2015;36:1619-1625. [PMID: 25528214 DOI: 10.1007/s13277-014-2760-9] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 7.0] [Reference Citation Analysis]
138 Penna E, Orso F, Taverna D. miR-214 as a key hub that controls cancer networks: small player, multiple functions. J Invest Dermatol. 2015;135:960-969. [PMID: 25501033 DOI: 10.1038/jid.2014.479] [Cited by in Crossref: 109] [Cited by in F6Publishing: 124] [Article Influence: 13.6] [Reference Citation Analysis]
139 Tan EJ, Olsson AK, Moustakas A. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ. Cell Adh Migr 2015;9:233-46. [PMID: 25482613 DOI: 10.4161/19336918.2014.983794] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
140 Comer BS, Ba M, Singer CA, Gerthoffer WT. Epigenetic targets for novel therapies of lung diseases. Pharmacol Ther 2015;147:91-110. [PMID: 25448041 DOI: 10.1016/j.pharmthera.2014.11.006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 6.6] [Reference Citation Analysis]
141 Ricciuti B, Mecca C, Crinò L, Baglivo S, Cenci M, Metro G. Non-coding RNAs in lung cancer. Oncoscience 2014;1:674-705. [PMID: 25593996 DOI: 10.18632/oncoscience.98] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
142 Liu MX, Zhou KC, Cao Y. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer. Mol Cancer 2014;13:245. [PMID: 25373388 DOI: 10.1186/1476-4598-13-245] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
143 Alečković M, Kang Y. Regulation of cancer metastasis by cell-free miRNAs. Biochim Biophys Acta 2015;1855:24-42. [PMID: 25450578 DOI: 10.1016/j.bbcan.2014.10.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 54] [Article Influence: 2.6] [Reference Citation Analysis]
144 Xu S, Xiao Y, Li L, Yu L, Jiang H, Yu A, Zeng S. Three new shRNA expression vectors targeting the CYP3A4 coding sequence to inhibit its expression. Acta Pharm Sin B 2014;4:350-7. [PMID: 26579404 DOI: 10.1016/j.apsb.2014.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
145 Mattiske S, Ho K, Noll JE, Neilsen PM, Callen DF, Suetani RJ. TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth. Oncotarget 2013;4:1894-903. [PMID: 24177167 DOI: 10.18632/oncotarget.1228] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
146 Schwarzenbach H. Circulating nucleic acids as biomarkers in breast cancer. Breast Cancer Res 2013;15:211. [PMID: 24090167 DOI: 10.1186/bcr3446] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 8.3] [Reference Citation Analysis]
147 Huang Y, Liu Y, Li L, Su B, Yang L, Fan W, Yin Q, Chen L, Cui T, Zhang J, Lu Y, Cheng J, Fu P, Liu F. Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury. BMC Nephrol 2014;15:142. [PMID: 25182190 DOI: 10.1186/1471-2369-15-142] [Cited by in Crossref: 68] [Cited by in F6Publishing: 77] [Article Influence: 8.5] [Reference Citation Analysis]
148 Ren ZJ, Nong XY, Lv YR, Sun HH, An PP, Wang F, Li X, Liu M, Tang H. Mir-509-5p joins the Mdm2/p53 feedback loop and regulates cancer cell growth. Cell Death Dis 2014;5:e1387. [PMID: 25144722 DOI: 10.1038/cddis.2014.327] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
149 Osborne LD, Li GZ, How T, O'Brien ET, Blobe GC, Superfine R, Mythreye K. TGF-β regulates LARG and GEF-H1 during EMT to affect stiffening response to force and cell invasion. Mol Biol Cell 2014;25:3528-40. [PMID: 25143398 DOI: 10.1091/mbc.E14-05-1015] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
150 Zeng H, Fang C, Nam S, Cai Q, Long X. The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis. Biomed Res Int 2014;2014:724209. [PMID: 25157366 DOI: 10.1155/2014/724209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
151 Chen J, Liu Z, Zhong G, Qian L, Li Z, Qiao Z, Chen B, Wang H. Hypertrophy of ligamentum flavum in lumbar spine stenosis is associated with increased miR-155 level. Dis Markers 2014;2014:786543. [PMID: 24963214 DOI: 10.1155/2014/786543] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
152 Shah NR, Chen H. MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment. World J Clin Oncol 2014; 5(2): 48-60 [PMID: 24829851 DOI: 10.5306/wjco.v5.i2.48] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
153 Zhou X, Hu Y, Dai L, Wang Y, Zhou J, Wang W, Di W, Qiu L. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer. PLoS One. 2014;9:e96718. [PMID: 24816687 DOI: 10.1371/journal.pone.0096718] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 7.9] [Reference Citation Analysis]
154 Zarzynska JM. Two faces of TGF-beta1 in breast cancer. Mediators Inflamm. 2014;2014:141747. [PMID: 24891760 DOI: 10.1155/2014/141747] [Cited by in Crossref: 115] [Cited by in F6Publishing: 134] [Article Influence: 14.4] [Reference Citation Analysis]
155 Santos JI, Teixeira AL, Dias F, Gomes M, Nogueira A, Assis J, Medeiros R. Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development. Tumour Biol 2014;35:6245-53. [PMID: 24763824 DOI: 10.1007/s13277-014-1887-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
156 Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178-196. [PMID: 24556840 DOI: 10.1038/nrm3758] [Cited by in Crossref: 3878] [Cited by in F6Publishing: 4346] [Article Influence: 484.8] [Reference Citation Analysis]
157 Hung CH, Chiu YC, Chen CH, Hu TH. MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target. Biomed Res Int. 2014;2014:486407. [PMID: 24800233 DOI: 10.1155/2014/486407] [Cited by in Crossref: 37] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
158 Zearo S, Kim E, Zhu Y, Zhao JT, Sidhu SB, Robinson BG, Soon PSh. MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers. BMC Cancer 2014;14:200. [PMID: 24641801 DOI: 10.1186/1471-2407-14-200] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 7.4] [Reference Citation Analysis]
159 Zhao JJ, Lin J, Zhu D, Wang X, Brooks D, Chen M, Chu ZB, Takada K, Ciccarelli B, Admin S, Tao J, Tai YT, Treon S, Pinkus G, Kuo WP, Hideshima T, Bouxsein M, Munshi N, Anderson K, Carrasco R. miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/β-catenin/BCL9 pathway. Cancer Res 2014;74:1801-13. [PMID: 24599134 DOI: 10.1158/0008-5472.CAN-13-3311-T] [Cited by in Crossref: 113] [Cited by in F6Publishing: 122] [Article Influence: 14.1] [Reference Citation Analysis]
160 Lin CW, Li XR, Zhang Y, Hu G, Guo YH, Zhou JY, Du J, Lv L, Gao K, Zhang Y. TAp63 suppress metastasis via miR-133b in colon cancer cells. Br J Cancer. 2014;110:2310-2320. [PMID: 24594999 DOI: 10.1038/bjc.2014.118] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
161 Peng Y, Liu YM, Li LC, Wang LL, Wu XL. microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition. Oncol Lett 2014;7:1233-8. [PMID: 24944699 DOI: 10.3892/ol.2014.1868] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
162 Weber M, Kim S, Patterson N, Rooney K, Searles CD. MiRNA-155 targets myosin light chain kinase and modulates actin cytoskeleton organization in endothelial cells. Am J Physiol Heart Circ Physiol 2014;306:H1192-203. [PMID: 24486510 DOI: 10.1152/ajpheart.00521.2013] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
163 Tang S, Bonaroti J, Unlu S, Liang X, Tang D, Zeh HJ, Lotze MT. Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer. Pancreas 2013;42:740-59. [PMID: 23774697 DOI: 10.1097/MPA.0b013e3182854ab0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
164 Paldino E, Tesori V, Casalbore P, Gasbarrini A, Puglisi MA. Tumor initiating cells and chemoresistance: which is the best strategy to target colon cancer stem cells? Biomed Res Int 2014;2014:859871. [PMID: 24527460 DOI: 10.1155/2014/859871] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
165 Gómez-Gómez Y, Organista-Nava J, Gariglio P. Deregulation of the miRNAs expression in cervical cancer: human papillomavirus implications. Biomed Res Int 2013;2013:407052. [PMID: 24490161 DOI: 10.1155/2013/407052] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
166 Stahlhut C, Slack FJ. MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications. Genome Med. 2013;5:111. [PMID: 24373327 DOI: 10.1186/gm516] [Cited by in Crossref: 101] [Cited by in F6Publishing: 109] [Article Influence: 11.2] [Reference Citation Analysis]
167 Sivadas VP, Kannan S. The microRNA networks of TGFβ signaling in cancer. Tumour Biol 2014;35:2857-69. [PMID: 24323563 DOI: 10.1007/s13277-013-1481-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
168 Zhou Y, Feng X, Liu YL, Ye SC, Wang H, Tan WK, Tian T, Qiu YM, Luo HS. Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathways. PLoS One. 2013;8:e81203. [PMID: 24312276 DOI: 10.1371/journal.pone.0081203] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 5.8] [Reference Citation Analysis]
169 Chen Y, Siegel F, Kipschull S, Haas B, Fröhlich H, Meister G, Pfeifer A. miR-155 regulates differentiation of brown and beige adipocytes via a bistable circuit. Nat Commun 2013;4:1769. [PMID: 23612310 DOI: 10.1038/ncomms2742] [Cited by in Crossref: 179] [Cited by in F6Publishing: 185] [Article Influence: 19.9] [Reference Citation Analysis]
170 Zhang CM, Zhao J, Deng HY. MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1. J Biomed Sci. 2013;20:79. [PMID: 24152184 DOI: 10.1186/1423-0127-20-79] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 8.0] [Reference Citation Analysis]
171 Charpentier MS, Taylor JM, Conlon FL. The CASZ1/Egfl7 transcriptional pathway is required for RhoA expression in vascular endothelial cells. Small GTPases 2013;4:231-5. [PMID: 24150064 DOI: 10.4161/sgtp.26849] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
172 Zhang B, Zhang Z, Xia S, Xing C, Ci X, Li X, Zhao R, Tian S, Ma G, Zhu Z, Fu L, Dong JT. KLF5 activates microRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelial-mesenchymal transition in epithelial cells. Mol Cell Biol 2013;33:4919-35. [PMID: 24126055 DOI: 10.1128/MCB.00787-13] [Cited by in Crossref: 58] [Cited by in F6Publishing: 66] [Article Influence: 6.4] [Reference Citation Analysis]
173 Shi S, Yu L, Zhang T, Qi H, Xavier S, Ju W, Bottinger E. Smad2-dependent downregulation of miR-30 is required for TGF-β-induced apoptosis in podocytes. PLoS One 2013;8:e75572. [PMID: 24086574 DOI: 10.1371/journal.pone.0075572] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
174 Vimalraj S, Miranda PJ, Ramyakrishna B, Selvamurugan N. Regulation of breast cancer and bone metastasis by microRNAs. Dis Markers. 2013;35:369-387. [PMID: 24191129 DOI: 10.1155/2013/451248] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 8.4] [Reference Citation Analysis]
175 Samatov TR, Tonevitsky AG, Schumacher U. Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds. Mol Cancer. 2013;12:107. [PMID: 24053443 DOI: 10.1186/1476-4598-12-107] [Cited by in Crossref: 86] [Cited by in F6Publishing: 90] [Article Influence: 9.6] [Reference Citation Analysis]
176 Ding XM. MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT). Chin J Cancer. 2014;33:140-147. [PMID: 24016392 DOI: 10.5732/cjc.013.10094] [Cited by in Crossref: 63] [Cited by in F6Publishing: 73] [Article Influence: 7.0] [Reference Citation Analysis]
177 Srivastava SP, Koya D, Kanasaki K. MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT. Biomed Res Int 2013;2013:125469. [PMID: 24089659 DOI: 10.1155/2013/125469] [Cited by in Crossref: 70] [Cited by in F6Publishing: 76] [Article Influence: 7.8] [Reference Citation Analysis]
178 Johansson J, Berg T, Kurzejamska E, Pang MF, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P, Fuxe J. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Oncogene 2013;32:5614-24. [PMID: 23955085 DOI: 10.1038/onc.2013.322] [Cited by in Crossref: 109] [Cited by in F6Publishing: 110] [Article Influence: 12.1] [Reference Citation Analysis]
179 Trajkovski M, Lodish H. MicroRNA networks regulate development of brown adipocytes. Trends Endocrinol Metab 2013;24:442-50. [PMID: 23809233 DOI: 10.1016/j.tem.2013.05.002] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 6.1] [Reference Citation Analysis]
180 Zhang J, Ma L. MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Rev 2012;31:653-62. [PMID: 22684369 DOI: 10.1007/s10555-012-9368-6] [Cited by in Crossref: 166] [Cited by in F6Publishing: 170] [Article Influence: 18.4] [Reference Citation Analysis]
181 Kato M, Dang V, Wang M, Park JT, Deshpande S, Kadam S, Mardiros A, Zhan Y, Oettgen P, Putta S, Yuan H, Lanting L, Natarajan R. TGF-β induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy. Sci Signal 2013;6:ra43. [PMID: 23737551 DOI: 10.1126/scisignal.2003389] [Cited by in Crossref: 92] [Cited by in F6Publishing: 90] [Article Influence: 10.2] [Reference Citation Analysis]
182 Marin T, Gongol B, Chen Z, Woo B, Subramaniam S, Chien S, Shyy JY. Mechanosensitive microRNAs-role in endothelial responses to shear stress and redox state. Free Radic Biol Med 2013;64:61-8. [PMID: 23727269 DOI: 10.1016/j.freeradbiomed.2013.05.034] [Cited by in Crossref: 78] [Cited by in F6Publishing: 84] [Article Influence: 8.7] [Reference Citation Analysis]
183 Puglisi MA, Tesori V, Lattanzi W, Gasbarrini GB, Gasbarrini A. Colon cancer stem cells: Controversies and perspectives. World J Gastroenterol 2013; 19(20): 2997-3006 [PMID: 23716979 DOI: 10.3748/wjg.v19.i20.2997] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
184 Szabo G, Bala S. MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol. 2013;10:542-552. [PMID: 23689081 DOI: 10.1038/nrgastro.2013.87] [Cited by in Crossref: 409] [Cited by in F6Publishing: 384] [Article Influence: 45.4] [Reference Citation Analysis]
185 Onyeagucha BC, Mercado-Pimentel ME, Hutchison J, Flemington EK, Nelson MA. S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer. Exp Cell Res 2013;319:2081-90. [PMID: 23693020 DOI: 10.1016/j.yexcr.2013.05.009] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
186 Zhang C, Zhao J, Deng H. 17β-estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells. Mol Cell Biochem 2013;379:201-11. [PMID: 23568502 DOI: 10.1007/s11010-013-1642-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
187 Haapa-Paananen S, Chen P, Hellström K, Kohonen P, Hautaniemi S, Kallioniemi O, Perälä M. Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation. PLoS One 2013;8:e60930. [PMID: 23577178 DOI: 10.1371/journal.pone.0060930] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
188 Chen D, Cabay RJ, Jin Y, Wang A, Lu Y, Shah-Khan M, Zhou X. MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas. J Oral Maxillofac Res 2013;4:e2. [PMID: 24422025 DOI: 10.5037/jomr.2013.4102] [Cited by in Crossref: 62] [Cited by in F6Publishing: 73] [Article Influence: 6.9] [Reference Citation Analysis]
189 Kishore R, Verma SK, Mackie AR, Vaughan EE, Abramova TV, Aiko I, Krishnamurthy P. Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts. PLoS One 2013;8:e60161. [PMID: 23560074 DOI: 10.1371/journal.pone.0060161] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
190 Liu J, van Mil A, Aguor EN, Siddiqi S, Vrijsen K, Jaksani S, Metz C, Zhao J, Strijkers GJ, Doevendans PA, Sluijter JP. MiR-155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPCs) via targeting of MMP-16. J Cell Mol Med 2012;16:2379-86. [PMID: 22348515 DOI: 10.1111/j.1582-4934.2012.01551.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
191 Smith HA, Kang Y. The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl). 2013;91:411-429. [PMID: 23515621 DOI: 10.1007/s00109-013-1021-5] [Cited by in Crossref: 221] [Cited by in F6Publishing: 216] [Article Influence: 24.6] [Reference Citation Analysis]
192 Morrison CD, Parvani JG, Schiemann WP. The relevance of the TGF-β Paradox to EMT-MET programs. Cancer Lett 2013;341:30-40. [PMID: 23474494 DOI: 10.1016/j.canlet.2013.02.048] [Cited by in Crossref: 125] [Cited by in F6Publishing: 137] [Article Influence: 13.9] [Reference Citation Analysis]
193 Wang Y, Zhou BP. Epithelial-mesenchymal Transition---A Hallmark of Breast Cancer Metastasis. Cancer Hallm 2013;1:38-49. [PMID: 24611128 DOI: 10.1166/ch.2013.1004] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 10.1] [Reference Citation Analysis]
194 Lamouille S, Subramanyam D, Blelloch R, Derynck R. Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Curr Opin Cell Biol. 2013;25:200-207. [PMID: 23434068 DOI: 10.1016/j.ceb.2013.01.008] [Cited by in Crossref: 189] [Cited by in F6Publishing: 183] [Article Influence: 21.0] [Reference Citation Analysis]
195 Wang J, Wang Y, Wang Y, Ma Y, Lan Y, Yang X. Transforming growth factor β-regulated microRNA-29a promotes angiogenesis through targeting the phosphatase and tensin homolog in endothelium. J Biol Chem. 2013;288:10418-10426. [PMID: 23426367 DOI: 10.1074/jbc.m112.444463] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
196 Brønnum H, Andersen DC, Schneider M, Sandberg MB, Eskildsen T, Nielsen SB, Kalluri R, Sheikh SP. miR-21 promotes fibrogenic epithelial-to-mesenchymal transition of epicardial mesothelial cells involving Programmed Cell Death 4 and Sprouty-1. PLoS One 2013;8:e56280. [PMID: 23441172 DOI: 10.1371/journal.pone.0056280] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 7.2] [Reference Citation Analysis]
197 Czyzyk-Krzeska MF, Zhang X. MiR-155 at the heart of oncogenic pathways. Oncogene 2014;33:677-8. [PMID: 23416982 DOI: 10.1038/onc.2013.26] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
198 Zhou H, Wang K, Hu Z, Wen J. TGF-β1 alters microRNA profile in human gastric cancer cells. Chin J Cancer Res. 2013;25:102-111. [PMID: 23372348 DOI: 10.3978/j.issn.1000-9604.2013.01.09] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
199 Kong W, He L, Richards EJ, Challa S, Xu CX, Permuth-Wey J, Lancaster JM, Coppola D, Sellers TA, Djeu JY. Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer. Oncogene. 2014;33:679-689. [PMID: 23353819 DOI: 10.1038/onc.2012.636] [Cited by in Crossref: 240] [Cited by in F6Publishing: 255] [Article Influence: 26.7] [Reference Citation Analysis]
200 Chen L, Li Y, Fu Y, Peng J, Mo MH, Stamatakos M, Teal CB, Brem RF, Stojadinovic A, Grinkemeyer M, McCaffrey TA, Man YG, Fu SW. Role of deregulated microRNAs in breast cancer progression using FFPE tissue. PLoS One 2013;8:e54213. [PMID: 23372687 DOI: 10.1371/journal.pone.0054213] [Cited by in Crossref: 61] [Cited by in F6Publishing: 68] [Article Influence: 6.8] [Reference Citation Analysis]
201 Singh R, Mo YY. Role of microRNAs in breast cancer. Cancer Biol Ther. 2013;14:201-212. [PMID: 23291983 DOI: 10.4161/cbt.23296] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 8.1] [Reference Citation Analysis]
202 Lebrun JJ. The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis. ISRN Mol Biol 2012;2012:381428. [PMID: 27340590 DOI: 10.5402/2012/381428] [Cited by in Crossref: 136] [Cited by in F6Publishing: 200] [Article Influence: 13.6] [Reference Citation Analysis]
203 Lei C, Wang Y, Huang Y, Yu H, Huang Y, Wu L, Huang L. Up-regulated miR155 reverses the epithelial-mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cells. PLoS One 2012;7:e52310. [PMID: 23284982 DOI: 10.1371/journal.pone.0052310] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
204 Taylor MA, Sossey-Alaoui K, Thompson CL, Danielpour D, Schiemann WP. TGF-β upregulates miR-181a expression to promote breast cancer metastasis. J Clin Invest 2013;123:150-63. [PMID: 23241956 DOI: 10.1172/JCI64946] [Cited by in Crossref: 195] [Cited by in F6Publishing: 210] [Article Influence: 19.5] [Reference Citation Analysis]
205 Chen W, Cai F, Zhang B, Barekati Z, Zhong XY. The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers. Tumour Biol. 2013;34:455-462. [PMID: 23238818 DOI: 10.1007/s13277-012-0570-5] [Cited by in Crossref: 103] [Cited by in F6Publishing: 101] [Article Influence: 10.3] [Reference Citation Analysis]
206 Chang HT, Li SC, Ho MR, Pan HW, Ger LP, Hu LY, Yu SY, Li WH, Tsai KW. Comprehensive analysis of microRNAs in breast cancer. BMC Genomics. 2012;13 Suppl 7:S18. [PMID: 23281739 DOI: 10.1186/1471-2164-13-s7-s18] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
207 Rather MI, Nagashri MN, Swamy SS, Gopinath KS, Kumar A. Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics. J Biol Chem. 2013;288:608-618. [PMID: 23166327 DOI: 10.1074/jbc.m112.425736] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 7.1] [Reference Citation Analysis]
208 Caruso S, Bazan V, Rolfo C, Insalaco L, Fanale D, Bronte G, Corsini LR, Rizzo S, Cicero G, Russo A. MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? Oncogenesis 2012;1:e32. [PMID: 23552465 DOI: 10.1038/oncsis.2012.33] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
209 Muñoz P, Iliou MS, Esteller M. Epigenetic alterations involved in cancer stem cell reprogramming. Mol Oncol 2012;6:620-36. [PMID: 23141800 DOI: 10.1016/j.molonc.2012.10.006] [Cited by in Crossref: 118] [Cited by in F6Publishing: 120] [Article Influence: 11.8] [Reference Citation Analysis]
210 Tang J, Ahmad A, Sarkar FH. The role of microRNAs in breast cancer migration, invasion and metastasis. Int J Mol Sci 2012;13:13414-37. [PMID: 23202960 DOI: 10.3390/ijms131013414] [Cited by in Crossref: 106] [Cited by in F6Publishing: 109] [Article Influence: 10.6] [Reference Citation Analysis]
211 Yang CS, Rana TM. Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs. Mol Biosyst 2013;9:10-7. [PMID: 23037570 DOI: 10.1039/c2mb25088h] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
212 Perng DW, Yang DM, Hsiao YH, Lo T, Lee OK, Wu MT, Wu YC, Lee YC. miRNA-146a expression positively regulates tumor necrosis factor-α-induced interleukin-8 production in mesenchymal stem cells and differentiated lung epithelial-like cells. Tissue Eng Part A 2012;18:2259-67. [PMID: 22876745 DOI: 10.1089/ten.TEA.2011.0634] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
213 Colas E, Pedrola N, Devis L, Ertekin T, Campoy I, Martínez E, Llauradó M, Rigau M, Olivan M, Garcia M, Cabrera S, Gil-Moreno A, Xercavins J, Castellvi J, Garcia A, Ramon y Cajal S, Moreno-Bueno G, Dolcet X, Alameda F, Palacios J, Prat J, Doll A, Matias-Guiu X, Abal M, Reventos J. The EMT signaling pathways in endometrial carcinoma. Clin Transl Oncol 2012;14:715-20. [PMID: 22911547 DOI: 10.1007/s12094-012-0866-3] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 6.7] [Reference Citation Analysis]
214 Zhang Y, Fan KJ, Sun Q, Chen AZ, Shen WL, Zhao ZH, Zheng XF, Yang X. Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-β signalling pathway. Nucleic Acids Res. 2012;40:9286-9297. [PMID: 22821565 DOI: 10.1093/nar/gks667] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 6.0] [Reference Citation Analysis]
215 Das LM, Torres-Castillo MD, Gill T, Levine AD. TGF-β conditions intestinal T cells to express increased levels of miR-155, associated with down-regulation of IL-2 and itk mRNA. Mucosal Immunol 2013;6:167-76. [PMID: 22785227 DOI: 10.1038/mi.2012.60] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
216 Cao M, Seike M, Soeno C, Mizutani H, Kitamura K, Minegishi Y, Noro R, Yoshimura A, Cai L, Gemma A. MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells. Int J Oncol 2012;41:869-75. [PMID: 22752005 DOI: 10.3892/ijo.2012.1535] [Cited by in Crossref: 112] [Cited by in F6Publishing: 126] [Article Influence: 11.2] [Reference Citation Analysis]
217 Unlu S, Tang S, Wang E, Martinez I, Tang D, Bianchi ME, Zeh HJ 3rd, Lotze MT. Damage associated molecular pattern molecule-induced microRNAs (DAMPmiRs) in human peripheral blood mononuclear cells. PLoS One 2012;7:e38899. [PMID: 22745684 DOI: 10.1371/journal.pone.0038899] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
218 Liu M, Bi F, Zhou X, Zheng Y. Rho GTPase regulation by miRNAs and covalent modifications. Trends Cell Biol 2012;22:365-73. [PMID: 22572609 DOI: 10.1016/j.tcb.2012.04.004] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 5.7] [Reference Citation Analysis]
219 Guo X, Chen SY. Transforming growth factor-β and smooth muscle differentiation. World J Biol Chem 2012; 3(3): 41-52 [PMID: 22451850 DOI: 10.4331/wjbc.v3.i3.41] [Cited by in CrossRef: 76] [Cited by in F6Publishing: 68] [Article Influence: 7.6] [Reference Citation Analysis]
220 Chen Z, Jin Y, Yu D, Wang A, Mahjabeen I, Wang C, Liu X, Zhou X. Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. Oral Oncol. 2012;48:686-691. [PMID: 22425712 DOI: 10.1016/j.oraloncology.2012.02.020] [Cited by in Crossref: 104] [Cited by in F6Publishing: 98] [Article Influence: 10.4] [Reference Citation Analysis]
221 Xing L, Yao X, Williams KR, Bassell GJ. Negative regulation of RhoA translation and signaling by hnRNP-Q1 affects cellular morphogenesis. Mol Biol Cell 2012;23:1500-9. [PMID: 22357624 DOI: 10.1091/mbc.E11-10-0867] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
222 Jiang S, Zhang LF, Zhang HW, Hu S, Lu MH, Liang S, Li B, Li Y, Li D, Wang ED, Liu MF. A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells. EMBO J. 2012;31:1985-1998. [PMID: 22354042 DOI: 10.1038/emboj.2012.45] [Cited by in Crossref: 219] [Cited by in F6Publishing: 228] [Article Influence: 21.9] [Reference Citation Analysis]
223 Zhang P, Bill K, Liu J, Young E, Peng T, Bolshakov S, Hoffman A, Song Y, Demicco EG, Terrada DL. MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling. Cancer Res. 2012;72:1751-1762. [PMID: 22350414 DOI: 10.1158/0008-5472.CAN-11-3027] [Cited by in Crossref: 70] [Cited by in F6Publishing: 77] [Article Influence: 7.0] [Reference Citation Analysis]
224 Sundqvist A, Ten Dijke P, van Dam H. Key signaling nodes in mammary gland development and cancer: Smad signal integration in epithelial cell plasticity. Breast Cancer Res 2012;14:204. [PMID: 22315972 DOI: 10.1186/bcr3066] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
225 Li S, Chen T, Zhong Z, Wang Y, Li Y, Zhao X. microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells. Mol Med Rep 2012;5:949-54. [PMID: 22307849 DOI: 10.3892/mmr.2012.779] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
226 Blahna MT, Hata A. Smad-mediated regulation of microRNA biosynthesis. FEBS Lett 2012;586:1906-12. [PMID: 22306316 DOI: 10.1016/j.febslet.2012.01.041] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 8.8] [Reference Citation Analysis]
227 Turcatel G, Rubin N, El-Hashash A, Warburton D. MIR-99a and MIR-99b modulate TGF-β induced epithelial to mesenchymal plasticity in normal murine mammary gland cells. PLoS One 2012;7:e31032. [PMID: 22299047 DOI: 10.1371/journal.pone.0031032] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 8.3] [Reference Citation Analysis]
228 Chang S, Sharan SK. Epigenetic control of an oncogenic microRNA, miR-155, by BRCA1. Oncotarget 2012;3:5-6. [PMID: 22403740 DOI: 10.18632/oncotarget.433] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
229 Zhang ZJ, Ma SL. miRNAs in breast cancer tumorigenesis (Review). Oncol Rep 2012;27:903-10. [PMID: 22200848 DOI: 10.3892/or.2011.1611] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
230 Dagan LN, Jiang X, Bhatt S, Cubedo E, Rajewsky K, Lossos IS. miR-155 regulates HGAL expression and increases lymphoma cell motility. Blood 2012;119:513-20. [PMID: 22096245 DOI: 10.1182/blood-2011-08-370536] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
231 Yu F, Jiao Y, Zhu Y, Wang Y, Zhu J, Cui X, Liu Y, He Y, Park EY, Zhang H. MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells. J Biol Chem. 2012;287:465-473. [PMID: 22074923 DOI: 10.1074/jbc.m111.280768] [Cited by in Crossref: 104] [Cited by in F6Publishing: 100] [Article Influence: 9.5] [Reference Citation Analysis]
232 Drasin DJ, Robin TP, Ford HL. Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity. Breast Cancer Res 2011;13:226. [PMID: 22078097 DOI: 10.1186/bcr3037] [Cited by in Crossref: 105] [Cited by in F6Publishing: 99] [Article Influence: 9.5] [Reference Citation Analysis]
233 Wang G, Tam LS, Kwan BC, Li EK, Chow KM, Luk CC, Li PK, Szeto CC. Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus. Clin Rheumatol 2012;31:435-40. [PMID: 21987229 DOI: 10.1007/s10067-011-1857-4] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
234 Singh MK, Lu MM, Massera D, Epstein JA. MicroRNA-processing enzyme Dicer is required in epicardium for coronary vasculature development. J Biol Chem 2011;286:41036-45. [PMID: 21969379 DOI: 10.1074/jbc.M111.268573] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
235 Li D, Liu X, Lin L, Hou J, Li N, Wang C, Wang P, Zhang Q, Zhang P, Zhou W. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem. 2011;286:36677-36685. [PMID: 21878637 DOI: 10.1074/jbc.m111.270561] [Cited by in Crossref: 165] [Cited by in F6Publishing: 161] [Article Influence: 15.0] [Reference Citation Analysis]
236 Tili E, Michaille JJ. Resveratrol, MicroRNAs, Inflammation, and Cancer. J Nucleic Acids. 2011;2011:102431. [PMID: 21845215 DOI: 10.4061/2011/102431] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 6.2] [Reference Citation Analysis]
237 Braun J, Hüttelmaier S. Pathogenic mechanisms of deregulated microRNA expression in thyroid carcinomas of follicular origin. Thyroid Res 2011;4 Suppl 1:S1. [PMID: 21835047 DOI: 10.1186/1756-6614-4-S1-S1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
238 Lössner C, Meier J, Warnken U, Rogers MA, Lichter P, Pscherer A, Schnölzer M. Quantitative proteomics identify novel miR-155 target proteins. PLoS One 2011;6:e22146. [PMID: 21799781 DOI: 10.1371/journal.pone.0022146] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
239 Valastyan S, Weinberg RA. Roles for microRNAs in the regulation of cell adhesion molecules. J Cell Sci 2011;124:999-1006. [PMID: 21402873 DOI: 10.1242/jcs.081513] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 7.1] [Reference Citation Analysis]
240 Giang Ho TT, Stultiens A, Dubail J, Lapière CM, Nusgens BV, Colige AC, Deroanne CF. RhoGDIα-dependent balance between RhoA and RhoC is a key regulator of cancer cell tumorigenesis. Mol Biol Cell 2011;22:3263-75. [PMID: 21757538 DOI: 10.1091/mbc.E11-01-0020] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
241 Long X, Miano JM. Transforming growth factor-beta1 (TGF-beta1) utilizes distinct pathways for the transcriptional activation of microRNA 143/145 in human coronary artery smooth muscle cells. J Biol Chem 2011;286:30119-29. [PMID: 21712382 DOI: 10.1074/jbc.M111.258814] [Cited by in Crossref: 98] [Cited by in F6Publishing: 100] [Article Influence: 8.9] [Reference Citation Analysis]
242 Kutanzi KR, Yurchenko OV, Beland FA, Checkhun VF, Pogribny IP. MicroRNA-mediated drug resistance in breast cancer. Clin Epigenetics 2011;2:171-85. [PMID: 21949547 DOI: 10.1007/s13148-011-0040-8] [Cited by in Crossref: 112] [Cited by in F6Publishing: 103] [Article Influence: 10.2] [Reference Citation Analysis]
243 Wendt MK, Tian M, Schiemann WP. Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression. Cell Tissue Res 2012;347:85-101. [PMID: 21691718 DOI: 10.1007/s00441-011-1199-1] [Cited by in Crossref: 149] [Cited by in F6Publishing: 147] [Article Influence: 13.5] [Reference Citation Analysis]
244 Zhu L, Chen H, Zhou D, Li D, Bai R, Zheng S, Ge W. MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility. Med Oncol. 2012;29:1037-1043. [PMID: 21562850 DOI: 10.1007/s12032-011-9975-z] [Cited by in Crossref: 63] [Cited by in F6Publishing: 76] [Article Influence: 5.7] [Reference Citation Analysis]
245 Brown RL, Reinke LM, Damerow MS, Perez D, Chodosh LA, Yang J, Cheng C. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest 2011;121:1064-74. [PMID: 21393860 DOI: 10.1172/JCI44540] [Cited by in Crossref: 376] [Cited by in F6Publishing: 377] [Article Influence: 34.2] [Reference Citation Analysis]
246 Du ZM, Hu LF, Wang HY, Yan LX, Zeng YX, Shao JY, Ernberg I. Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. PLoS One 2011;6:e19137. [PMID: 21541331 DOI: 10.1371/journal.pone.0019137] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 6.4] [Reference Citation Analysis]
247 Liang S, He L, Zhao X, Miao Y, Gu Y, Guo C, Xue Z, Dou W, Hu F, Wu K, Nie Y, Fan D. MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS One 2011;6:e18409. [PMID: 21533124 DOI: 10.1371/journal.pone.0018409] [Cited by in Crossref: 119] [Cited by in F6Publishing: 123] [Article Influence: 10.8] [Reference Citation Analysis]
248 Sotillo E, Thomas-Tikhonenko A. Shielding the messenger (RNA): microRNA-based anticancer therapies. Pharmacol Ther. 2011;131:18-32. [PMID: 21514318 DOI: 10.1016/j.pharmthera.2011.04.006] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.0] [Reference Citation Analysis]
249 Xiang X, Zhuang X, Ju S, Zhang S, Jiang H, Mu J, Zhang L, Miller D, Grizzle W, Zhang HG. miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT. Oncogene. 2011;30:3440-3453. [PMID: 21460854 DOI: 10.1038/onc.2011.54] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 6.4] [Reference Citation Analysis]
250 Parvani JG, Taylor MA, Schiemann WP. Noncanonical TGF-β signaling during mammary tumorigenesis. J Mammary Gland Biol Neoplasia 2011;16:127-46. [PMID: 21448580 DOI: 10.1007/s10911-011-9207-3] [Cited by in Crossref: 77] [Cited by in F6Publishing: 90] [Article Influence: 7.0] [Reference Citation Analysis]
251 Dogar AM, Towbin H, Hall J. Suppression of latent transforming growth factor (TGF)-beta1 restores growth inhibitory TGF-beta signaling through microRNAs. J Biol Chem 2011;286:16447-58. [PMID: 21402698 DOI: 10.1074/jbc.M110.208652] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
252 Sato T, Liu X, Basma H, Togo S, Sugiura H, Nelson A, Nakanishi M, Kanaji N, Wang X, Kim M, Li Y, Michalski J, Farid M, Sharp JG, Rennard SI. IL-4 induces differentiation of human embryonic stem cells into fibrogenic fibroblast-like cells. J Allergy Clin Immunol 2011;127:1595-603.e9. [PMID: 21388667 DOI: 10.1016/j.jaci.2011.01.049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
253 Fu SW, Chen L, Man YG. miRNA Biomarkers in Breast Cancer Detection and Management. J Cancer 2011;2:116-22. [PMID: 21479130 DOI: 10.7150/jca.2.116] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 6.2] [Reference Citation Analysis]
254 Park JY, Helm J, Coppola D, Kim D, Malafa M, Kim SJ. MicroRNAs in pancreatic ductal adenocarcinoma. World J Gastroenterol 2011; 17(7): 817-827 [PMID: 21412491 DOI: 10.3748/wjg.v17.i7.817] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
255 Winbanks CE, Wang B, Beyer C, Koh P, White L, Kantharidis P, Gregorevic P. TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. J Biol Chem. 2011;286:13805-13814. [PMID: 21324893 DOI: 10.1074/jbc.m110.192625] [Cited by in Crossref: 185] [Cited by in F6Publishing: 195] [Article Influence: 16.8] [Reference Citation Analysis]
256 Aigner A. MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs. J Mol Med (Berl) 2011;89:445-57. [PMID: 21234533 DOI: 10.1007/s00109-010-0716-0] [Cited by in Crossref: 100] [Cited by in F6Publishing: 85] [Article Influence: 9.1] [Reference Citation Analysis]
257 Zhai H, Ju J. Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics. Front Genet 2011;2:00078. [PMID: 22114584 DOI: 10.3389/fgene.2011.00078] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
258 Wang HG, Huang XD, Ji GZ. EMT- and microRNA-related signaling pathways in tumors. Shijie Huaren Xiaohua Zazhi 2010; 18(34): 3672-3678 [DOI: 10.11569/wcjd.v18.i34.3672] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
259 Roy S, Sen CK. MiRNA in innate immune responses: novel players in wound inflammation. Physiol Genomics 2011;43:557-65. [PMID: 21139022 DOI: 10.1152/physiolgenomics.00160.2010] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 7.2] [Reference Citation Analysis]
260 Wang Y, Yu Y, Tsuyada A, Ren X, Wu X, Stubblefield K, Rankin-Gee EK, Wang SE. Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene. 2011;30:1470-1480. [PMID: 21102523 DOI: 10.1038/onc.2010.531] [Cited by in Crossref: 203] [Cited by in F6Publishing: 200] [Article Influence: 16.9] [Reference Citation Analysis]
261 Ucar A, Vafaizadeh V, Jarry H, Fiedler J, Klemmt PA, Thum T, Groner B, Chowdhury K. miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. Nat Genet 2010;42:1101-8. [PMID: 21057503 DOI: 10.1038/ng.709] [Cited by in Crossref: 118] [Cited by in F6Publishing: 117] [Article Influence: 9.8] [Reference Citation Analysis]
262 Roth C, Rack B, Müller V, Janni W, Pantel K, Schwarzenbach H. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res. 2010;12:R90. [PMID: 21047409 DOI: 10.1186/bcr2766] [Cited by in Crossref: 291] [Cited by in F6Publishing: 272] [Article Influence: 24.3] [Reference Citation Analysis]
263 White NM, Fatoohi E, Metias M, Jung K, Stephan C, Yousef GM. Metastamirs: a stepping stone towards improved cancer management. Nat Rev Clin Oncol. 2011;8:75-84. [PMID: 21045789 DOI: 10.1038/nrclinonc.2010.173] [Cited by in Crossref: 136] [Cited by in F6Publishing: 135] [Article Influence: 11.3] [Reference Citation Analysis]
264 Lamouille S, Derynck R. Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-β-induced epithelial-mesenchymal transition. Cells Tissues Organs. 2011;193:8-22. [PMID: 21041997 DOI: 10.1159/000320172] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 5.0] [Reference Citation Analysis]
265 Louafi F, Martinez-Nunez RT, Sanchez-Elsner T. MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. J Biol Chem 2010;285:41328-36. [PMID: 21036908 DOI: 10.1074/jbc.M110.146852] [Cited by in Crossref: 141] [Cited by in F6Publishing: 141] [Article Influence: 11.8] [Reference Citation Analysis]
266 Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, Thannickal VJ, Cardoso WV, Lü J. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 2011;45:287-94. [PMID: 20971881 DOI: 10.1165/rcmb.2010-0323OC] [Cited by in Crossref: 313] [Cited by in F6Publishing: 318] [Article Influence: 26.1] [Reference Citation Analysis]
267 Zhou Q, Fan J, Ding X, Peng W, Yu X, Chen Y, Nie J. TGF-{beta}-induced MiR-491-5p expression promotes Par-3 degradation in rat proximal tubular epithelial cells. J Biol Chem. 2010;285:40019-40027. [PMID: 20966078 DOI: 10.1074/jbc.m110.141341] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
268 Lin Z, Flemington EK. miRNAs in the pathogenesis of oncogenic human viruses. Cancer Lett. 2011;305:186-199. [PMID: 20943311 DOI: 10.1016/j.canlet.2010.08.018] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
269 Kriegel AJ, Fang Y, Liu Y, Tian Z, Mladinov D, Matus IR, Ding X, Greene AS, Liang M. MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor beta 1: a novel role of miR-382. Nucleic Acids Res 2010;38:8338-47. [PMID: 20716515 DOI: 10.1093/nar/gkq718] [Cited by in Crossref: 87] [Cited by in F6Publishing: 94] [Article Influence: 7.3] [Reference Citation Analysis]
270 Wang H, Chen X, Wang H, Zhang H. [Advances of microRNAs correlated with invasion and metastasis of tumors]. Zhongguo Fei Ai Za Zhi 2010;13:144-8. [PMID: 20673508 DOI: 10.3779/j.issn.1009-3419.2010.02.13] [Reference Citation Analysis]
271 Pan H, Bachelder RE. Autocrine Semaphorin3A stimulates eukaryotic initiation factor 4E-dependent RhoA translation in breast tumor cells. Exp Cell Res 2010;316:2825-32. [PMID: 20655307 DOI: 10.1016/j.yexcr.2010.07.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
272 Heneghan HM, Miller N, Kelly R, Newell J, Kerin MJ. Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist. 2010;15:673-682. [PMID: 20576643 DOI: 10.1634/theoncologist.2010-0103] [Cited by in Crossref: 220] [Cited by in F6Publishing: 208] [Article Influence: 18.3] [Reference Citation Analysis]
273 Jiang L, Huang Q, Zhang S, Zhang Q, Chang J, Qiu X, Wang E. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. BMC Cancer. 2010;10:318. [PMID: 20569443 DOI: 10.1186/1471-2407-10-318] [Cited by in Crossref: 148] [Cited by in F6Publishing: 159] [Article Influence: 12.3] [Reference Citation Analysis]
274 Vetter G, Saumet A, Moes M, Vallar L, Le Béchec A, Laurini C, Sabbah M, Arar K, Theillet C, Lecellier CH. miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers. Oncogene. 2010;29:4436-4448. [PMID: 20543867 DOI: 10.1038/onc.2010.181] [Cited by in Crossref: 94] [Cited by in F6Publishing: 90] [Article Influence: 7.8] [Reference Citation Analysis]
275 Lee J, Moon HJ, Lee JM, Joo CK. Smad3 regulates Rho signaling via NET1 in the transforming growth factor-beta-induced epithelial-mesenchymal transition of human retinal pigment epithelial cells. J Biol Chem 2010;285:26618-27. [PMID: 20547485 DOI: 10.1074/jbc.M109.073155] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
276 Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29:4741-4751. [PMID: 20531305 DOI: 10.1038/onc.2010.215] [Cited by in Crossref: 1663] [Cited by in F6Publishing: 1698] [Article Influence: 138.6] [Reference Citation Analysis]
277 Beezhold KJ, Castranova V, Chen F. Microprocessor of microRNAs: regulation and potential for therapeutic intervention. Mol Cancer 2010;9:134. [PMID: 20515486 DOI: 10.1186/1476-4598-9-134] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
278 Taylor MA, Parvani JG, Schiemann WP. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells. J Mammary Gland Biol Neoplasia. 2010;15:169-190. [PMID: 20467795 DOI: 10.1007/s10911-010-9181-1] [Cited by in Crossref: 145] [Cited by in F6Publishing: 157] [Article Influence: 12.1] [Reference Citation Analysis]
279 Li M, Li J, Ding X, He M, Cheng SY. microRNA and cancer. AAPS J 2010;12:309-17. [PMID: 20422339 DOI: 10.1208/s12248-010-9194-0] [Cited by in Crossref: 99] [Cited by in F6Publishing: 100] [Article Influence: 8.3] [Reference Citation Analysis]
280 Kong W, He L, Coppola M, Guo J, Esposito NN, Coppola D, Cheng JQ. MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem. 2010;285:17869-17879. [PMID: 20371610 DOI: 10.1074/jbc.m110.101055] [Cited by in Crossref: 260] [Cited by in F6Publishing: 235] [Article Influence: 21.7] [Reference Citation Analysis]
281 Ryu JK, Hong SM, Karikari CA, Hruban RH, Goggins MG, Maitra A. Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. Pancreatology. 2010;10:66-73. [PMID: 20332664 DOI: 10.1159/000231984] [Cited by in Crossref: 82] [Cited by in F6Publishing: 90] [Article Influence: 6.8] [Reference Citation Analysis]
282 O'Day E, Lal A. MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 2010;12:201. [PMID: 20346098 DOI: 10.1186/bcr2484] [Cited by in Crossref: 295] [Cited by in F6Publishing: 284] [Article Influence: 24.6] [Reference Citation Analysis]
283 Ouyang G, Wang Z, Fang X, Liu J, Yang CJ. Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells. Cell Mol Life Sci. 2010;67:2605-2618. [PMID: 20238234 DOI: 10.1007/s00018-010-0338-2] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 5.9] [Reference Citation Analysis]
284 Davidson-Moncada J, Papavasiliou FN, Tam W. MicroRNAs of the immune system: roles in inflammation and cancer. Ann N Y Acad Sci. 2010;1183:183-194. [PMID: 20146715 DOI: 10.1111/j.1749-6632.2009.05121.x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 121] [Article Influence: 9.6] [Reference Citation Analysis]
285 Baranwal S, Alahari SK. miRNA control of tumor cell invasion and metastasis. Int J Cancer. 2010;126:1283-1290. [PMID: 19877123 DOI: 10.1002/ijc.25014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 129] [Article Influence: 3.3] [Reference Citation Analysis]
286 Le XF, Merchant O, Bast RC, Calin GA. The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade. Cancer Microenviron 2010;3:137-47. [PMID: 21209780 DOI: 10.1007/s12307-010-0037-4] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 5.9] [Reference Citation Analysis]
287 Wendt MK, Allington TM, Schiemann WP. Mechanisms of the epithelial-mesenchymal transition by TGF-beta. Future Oncol. 2009;5:1145-1168. [PMID: 19852727 DOI: 10.2217/fon.09.90] [Cited by in Crossref: 198] [Cited by in F6Publishing: 210] [Article Influence: 16.5] [Reference Citation Analysis]
288 Yao G, Yin M, Lian J, Tian H, Liu L, Li X, Sun F. MicroRNA-224 is involved in transforming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4. Mol Endocrinol. 2010;24:540-551. [PMID: 20118412 DOI: 10.1210/me.2009-0432] [Cited by in Crossref: 206] [Cited by in F6Publishing: 212] [Article Influence: 17.2] [Reference Citation Analysis]
289 Pais H, Nicolas FE, Soond SM, Swingler TE, Clark IM, Chantry A, Moulton V, Dalmay T. Analyzing mRNA expression identifies Smad3 as a microRNA-140 target regulated only at protein level. RNA 2010;16:489-94. [PMID: 20071455 DOI: 10.1261/rna.1701210] [Cited by in Crossref: 85] [Cited by in F6Publishing: 84] [Article Influence: 7.1] [Reference Citation Analysis]
290 Yang G, Yang X. Smad4-mediated TGF-beta signaling in tumorigenesis. Int J Biol Sci 2010;6:1-8. [PMID: 20087440 DOI: 10.7150/ijbs.6.1] [Cited by in Crossref: 80] [Cited by in F6Publishing: 102] [Article Influence: 6.7] [Reference Citation Analysis]
291 Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, Ghoshal K. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene. 2010;29:1787-1797. [PMID: 20023698 DOI: 10.1038/onc.2009.468] [Cited by in Crossref: 254] [Cited by in F6Publishing: 270] [Article Influence: 19.5] [Reference Citation Analysis]
292 Kato M, Arce L, Natarajan R. MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol 2009;4:1255-66. [PMID: 19581401 DOI: 10.2215/CJN.00520109] [Cited by in Crossref: 118] [Cited by in F6Publishing: 119] [Article Influence: 9.1] [Reference Citation Analysis]
293 Edmonds MD, Hurst DR, Vaidya KS, Stafford LJ, Chen D, Welch DR. Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression. Int J Cancer. 2009;125:1778-1785. [PMID: 19585508 DOI: 10.1002/ijc.24616] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 4.8] [Reference Citation Analysis]
294 Pottier N, Maurin T, Chevalier B, Puisségur MP, Lebrigand K, Robbe-Sermesant K, Bertero T, Lino Cardenas CL, Courcot E, Rios G, Fourre S, Lo-Guidice JM, Marcet B, Cardinaud B, Barbry P, Mari B. Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS One 2009;4:e6718. [PMID: 19701459 DOI: 10.1371/journal.pone.0006718] [Cited by in Crossref: 149] [Cited by in F6Publishing: 149] [Article Influence: 11.5] [Reference Citation Analysis]
295 Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene. 2009;28:3526-3536. [PMID: 19617899 DOI: 10.1038/onc.2009.211] [Cited by in Crossref: 484] [Cited by in F6Publishing: 495] [Article Influence: 37.2] [Reference Citation Analysis]
296 Liu X, Chen Z, Yu J, Xia J, Zhou X. MicroRNA profiling and head and neck cancer. Comp Funct Genomics. 2009;837514. [PMID: 19753298 DOI: 10.1155/2009/837514] [Cited by in Crossref: 59] [Cited by in F6Publishing: 85] [Article Influence: 4.5] [Reference Citation Analysis]
297 Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA. MicroRNAs--the micro steering wheel of tumour metastases. Nat Rev Cancer. 2009;9:293-302. [PMID: 19262572 DOI: 10.1038/nrc2619] [Cited by in Crossref: 567] [Cited by in F6Publishing: 545] [Article Influence: 43.6] [Reference Citation Analysis]
298 Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, Pierre P. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci USA. 2009;106:2735-2740. [PMID: 19193853 DOI: 10.1073/pnas.0811073106] [Cited by in Crossref: 500] [Cited by in F6Publishing: 509] [Article Influence: 38.5] [Reference Citation Analysis]
299 Bouzar AB, Willems L. How HTLV-1 may subvert miRNAs for persistence and transformation. Retrovirology 2008;5:101. [PMID: 19014483 DOI: 10.1186/1742-4690-5-101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]